Covid-19 Impact on Global Antirheumatics Pharmaceutical Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-antirheumatics-pharmaceutical-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Antirheumatics Pharmaceutical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antirheumatics Pharmaceutical development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- AbbVie
- Amgen
- Pfizer
- Roche Holding AG
- Novartis International AG
- Johnson & Johnson
- Bristol-Myers Squibb
- Merck
- UCB S.A.
- Eli Lilly and Company
- Non-Steroidal Anti-Inflammatory Drugs
- Steroidal Anti-Inflammatory Drugs
- Slow Acting Drug
- Immunological Preparation
- Pharmaceutical Industry
- Hospital and Clinic
- Other
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Antirheumatics Pharmaceutical status, future forecast, growth opportunity, key market and key players.
- To present the Antirheumatics Pharmaceutical development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-Steroidal Anti-Inflammatory Drugs
1.4.3 Steroidal Anti-Inflammatory Drugs
1.4.4 Slow Acting Drug
1.4.5 Immunological Preparation
1.5 Market by Application
1.5.1 Global Antirheumatics Pharmaceutical Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Industry
1.5.3 Hospital and Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Antirheumatics Pharmaceutical Industry Impact
1.6.1 How the Covid-19 is Affecting the Antirheumatics Pharmaceutical Industry
1.6.1.1 Antirheumatics Pharmaceutical Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antirheumatics Pharmaceutical Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antirheumatics Pharmaceutical Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Antirheumatics Pharmaceutical Market Perspective (2015-2026)
2.2 Antirheumatics Pharmaceutical Growth Trends by Regions
2.2.1 Antirheumatics Pharmaceutical Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antirheumatics Pharmaceutical Historic Market Share by Regions (2015-2020)
2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Antirheumatics Pharmaceutical Market Growth Strategy
2.3.6 Primary Interviews with Key Antirheumatics Pharmaceutical Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Antirheumatics Pharmaceutical Players by Market Size
3.1.1 Global Top Antirheumatics Pharmaceutical Players by Revenue (2015-2020)
3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2015-2020)
3.1.3 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antirheumatics Pharmaceutical Market Concentration Ratio
3.2.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2019
3.3 Antirheumatics Pharmaceutical Key Players Head office and Area Served
3.4 Key Players Antirheumatics Pharmaceutical Product Solution and Service
3.5 Date of Enter into Antirheumatics Pharmaceutical Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2015-2020)
4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2021-2026)
5 ANTIRHEUMATICS PHARMACEUTICAL BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antirheumatics Pharmaceutical Market Size (2015-2020)
6.2 Antirheumatics Pharmaceutical Key Players in North America (2019-2020)
6.3 North America Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
6.4 North America Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Antirheumatics Pharmaceutical Market Size (2015-2020)
7.2 Antirheumatics Pharmaceutical Key Players in Europe (2019-2020)
7.3 Europe Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
7.4 Europe Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
8 CHINA
8.1 China Antirheumatics Pharmaceutical Market Size (2015-2020)
8.2 Antirheumatics Pharmaceutical Key Players in China (2019-2020)
8.3 China Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
8.4 China Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Antirheumatics Pharmaceutical Market Size (2015-2020)
9.2 Antirheumatics Pharmaceutical Key Players in Japan (2019-2020)
9.3 Japan Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
9.4 Japan Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Antirheumatics Pharmaceutical Market Size (2015-2020)
10.2 Antirheumatics Pharmaceutical Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
10.4 Southeast Asia Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
11 INDIA
11.1 India Antirheumatics Pharmaceutical Market Size (2015-2020)
11.2 Antirheumatics Pharmaceutical Key Players in India (2019-2020)
11.3 India Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
11.4 India Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Antirheumatics Pharmaceutical Market Size (2015-2020)
12.2 Antirheumatics Pharmaceutical Key Players in Central & South America (2019-2020)
12.3 Central & South America Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
12.4 Central & South America Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie Antirheumatics Pharmaceutical Introduction
13.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview and Its Total Revenue
13.2.3 Amgen Antirheumatics Pharmaceutical Introduction
13.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Antirheumatics Pharmaceutical Introduction
13.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Roche Holding AG
13.4.1 Roche Holding AG Company Details
13.4.2 Roche Holding AG Business Overview and Its Total Revenue
13.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction
13.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.4.5 Roche Holding AG Recent Development
13.5 Novartis International AG
13.5.1 Novartis International AG Company Details
13.5.2 Novartis International AG Business Overview and Its Total Revenue
13.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction
13.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.5.5 Novartis International AG Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
13.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction
13.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction
13.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview and Its Total Revenue
13.8.3 Merck Antirheumatics Pharmaceutical Introduction
13.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.8.5 Merck Recent Development
13.9 UCB S.A.
13.9.1 UCB S.A. Company Details
13.9.2 UCB S.A. Business Overview and Its Total Revenue
13.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction
13.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.9.5 UCB S.A. Recent Development
13.10 Eli Lilly and Company
13.10.1 Eli Lilly and Company Company Details
13.10.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction
13.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.10.5 Eli Lilly and Company Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-Steroidal Anti-Inflammatory Drugs
1.4.3 Steroidal Anti-Inflammatory Drugs
1.4.4 Slow Acting Drug
1.4.5 Immunological Preparation
1.5 Market by Application
1.5.1 Global Antirheumatics Pharmaceutical Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Industry
1.5.3 Hospital and Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Antirheumatics Pharmaceutical Industry Impact
1.6.1 How the Covid-19 is Affecting the Antirheumatics Pharmaceutical Industry
1.6.1.1 Antirheumatics Pharmaceutical Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antirheumatics Pharmaceutical Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antirheumatics Pharmaceutical Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Antirheumatics Pharmaceutical Market Perspective (2015-2026)
2.2 Antirheumatics Pharmaceutical Growth Trends by Regions
2.2.1 Antirheumatics Pharmaceutical Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antirheumatics Pharmaceutical Historic Market Share by Regions (2015-2020)
2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Antirheumatics Pharmaceutical Market Growth Strategy
2.3.6 Primary Interviews with Key Antirheumatics Pharmaceutical Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Antirheumatics Pharmaceutical Players by Market Size
3.1.1 Global Top Antirheumatics Pharmaceutical Players by Revenue (2015-2020)
3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2015-2020)
3.1.3 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antirheumatics Pharmaceutical Market Concentration Ratio
3.2.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2019
3.3 Antirheumatics Pharmaceutical Key Players Head office and Area Served
3.4 Key Players Antirheumatics Pharmaceutical Product Solution and Service
3.5 Date of Enter into Antirheumatics Pharmaceutical Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2015-2020)
4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2021-2026)
5 ANTIRHEUMATICS PHARMACEUTICAL BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antirheumatics Pharmaceutical Market Size (2015-2020)
6.2 Antirheumatics Pharmaceutical Key Players in North America (2019-2020)
6.3 North America Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
6.4 North America Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Antirheumatics Pharmaceutical Market Size (2015-2020)
7.2 Antirheumatics Pharmaceutical Key Players in Europe (2019-2020)
7.3 Europe Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
7.4 Europe Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
8 CHINA
8.1 China Antirheumatics Pharmaceutical Market Size (2015-2020)
8.2 Antirheumatics Pharmaceutical Key Players in China (2019-2020)
8.3 China Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
8.4 China Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Antirheumatics Pharmaceutical Market Size (2015-2020)
9.2 Antirheumatics Pharmaceutical Key Players in Japan (2019-2020)
9.3 Japan Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
9.4 Japan Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Antirheumatics Pharmaceutical Market Size (2015-2020)
10.2 Antirheumatics Pharmaceutical Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
10.4 Southeast Asia Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
11 INDIA
11.1 India Antirheumatics Pharmaceutical Market Size (2015-2020)
11.2 Antirheumatics Pharmaceutical Key Players in India (2019-2020)
11.3 India Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
11.4 India Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Antirheumatics Pharmaceutical Market Size (2015-2020)
12.2 Antirheumatics Pharmaceutical Key Players in Central & South America (2019-2020)
12.3 Central & South America Antirheumatics Pharmaceutical Market Size by Type (2015-2020)
12.4 Central & South America Antirheumatics Pharmaceutical Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie Antirheumatics Pharmaceutical Introduction
13.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview and Its Total Revenue
13.2.3 Amgen Antirheumatics Pharmaceutical Introduction
13.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Antirheumatics Pharmaceutical Introduction
13.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Roche Holding AG
13.4.1 Roche Holding AG Company Details
13.4.2 Roche Holding AG Business Overview and Its Total Revenue
13.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction
13.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.4.5 Roche Holding AG Recent Development
13.5 Novartis International AG
13.5.1 Novartis International AG Company Details
13.5.2 Novartis International AG Business Overview and Its Total Revenue
13.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction
13.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.5.5 Novartis International AG Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
13.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction
13.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction
13.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview and Its Total Revenue
13.8.3 Merck Antirheumatics Pharmaceutical Introduction
13.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.8.5 Merck Recent Development
13.9 UCB S.A.
13.9.1 UCB S.A. Company Details
13.9.2 UCB S.A. Business Overview and Its Total Revenue
13.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction
13.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.9.5 UCB S.A. Recent Development
13.10 Eli Lilly and Company
13.10.1 Eli Lilly and Company Company Details
13.10.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction
13.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2015-2020)
13.10.5 Eli Lilly and Company Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Antirheumatics Pharmaceutical Key Market Segments
Table 2. Key Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
Table 3. Ranking of Global Top Antirheumatics Pharmaceutical Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 6. Key Players of Steroidal Anti-Inflammatory Drugs
Table 7. Key Players of Slow Acting Drug
Table 8. Key Players of Immunological Preparation
Table 9. COVID-19 Impact Global Market: (Four Antirheumatics Pharmaceutical Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Antirheumatics Pharmaceutical Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Antirheumatics Pharmaceutical Players to Combat Covid-19 Impact
Table 14. Global Antirheumatics Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Antirheumatics Pharmaceutical Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Antirheumatics Pharmaceutical Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Antirheumatics Pharmaceutical Market Share by Regions (2015-2020)
Table 18. Global Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Antirheumatics Pharmaceutical Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Antirheumatics Pharmaceutical Market Growth Strategy
Table 24. Main Points Interviewed from Key Antirheumatics Pharmaceutical Players
Table 25. Global Antirheumatics Pharmaceutical Revenue by Players (2015-2020) (Million US$)
Table 26. Global Antirheumatics Pharmaceutical Market Share by Players (2015-2020)
Table 27. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2019)
Table 28. Global Antirheumatics Pharmaceutical by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Antirheumatics Pharmaceutical Product Solution and Service
Table 31. Date of Enter into Antirheumatics Pharmaceutical Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 34. Global Antirheumatics Pharmaceutical Market Size Share by Type (2015-2020)
Table 35. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2021-2026)
Table 36. Global Antirheumatics Pharmaceutical Market Size Share by Application (2015-2020)
Table 37. Global Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 38. Global Antirheumatics Pharmaceutical Market Size Share by Application (2021-2026)
Table 39. North America Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 41. North America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 42. North America Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 43. North America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 44. North America Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 45. Europe Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 47. Europe Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 49. Europe Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 51. China Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 52. China Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 53. China Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 54. China Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 55. China Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 56. China Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 57. Japan Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 59. Japan Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 61. Japan Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 65. Southeast Asia Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 67. Southeast Asia Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 69. India Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 70. India Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 71. India Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 72. India Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 73. India Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 74. India Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 77. Central & South America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 79. Central & South America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Product
Table 84. AbbVie Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 85. AbbVie Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Product
Table 89. Amgen Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 90. Amgen Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Roche Holding AG Company Details
Table 97. Roche Holding AG Business Overview
Table 98. Roche Holding AG Product
Table 99. Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 100. Roche Holding AG Recent Development
Table 101. Novartis International AG Company Details
Table 102. Novartis International AG Business Overview
Table 103. Novartis International AG Product
Table 104. Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 105. Novartis International AG Recent Development
Table 106. Johnson & Johnson Company Details
Table 107. Johnson & Johnson Business Overview
Table 108. Johnson & Johnson Product
Table 109. Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 110. Johnson & Johnson Recent Development
Table 111. Bristol-Myers Squibb Company Details
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Product
Table 114. Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 115. Bristol-Myers Squibb Recent Development
Table 116. Merck Business Overview
Table 117. Merck Product
Table 118. Merck Company Details
Table 119. Merck Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 120. Merck Recent Development
Table 121. UCB S.A. Company Details
Table 122. UCB S.A. Business Overview
Table 123. UCB S.A. Product
Table 124. UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 125. UCB S.A. Recent Development
Table 126. Eli Lilly and Company Company Details
Table 127. Eli Lilly and Company Business Overview
Table 128. Eli Lilly and Company Product
Table 129. Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 130. Eli Lilly and Company Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 1. Antirheumatics Pharmaceutical Key Market Segments
Table 2. Key Players Covered: Ranking by Antirheumatics Pharmaceutical Revenue
Table 3. Ranking of Global Top Antirheumatics Pharmaceutical Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 6. Key Players of Steroidal Anti-Inflammatory Drugs
Table 7. Key Players of Slow Acting Drug
Table 8. Key Players of Immunological Preparation
Table 9. COVID-19 Impact Global Market: (Four Antirheumatics Pharmaceutical Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Antirheumatics Pharmaceutical Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Antirheumatics Pharmaceutical Players to Combat Covid-19 Impact
Table 14. Global Antirheumatics Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Antirheumatics Pharmaceutical Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Antirheumatics Pharmaceutical Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Antirheumatics Pharmaceutical Market Share by Regions (2015-2020)
Table 18. Global Antirheumatics Pharmaceutical Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Antirheumatics Pharmaceutical Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Antirheumatics Pharmaceutical Market Growth Strategy
Table 24. Main Points Interviewed from Key Antirheumatics Pharmaceutical Players
Table 25. Global Antirheumatics Pharmaceutical Revenue by Players (2015-2020) (Million US$)
Table 26. Global Antirheumatics Pharmaceutical Market Share by Players (2015-2020)
Table 27. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2019)
Table 28. Global Antirheumatics Pharmaceutical by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Antirheumatics Pharmaceutical Product Solution and Service
Table 31. Date of Enter into Antirheumatics Pharmaceutical Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 34. Global Antirheumatics Pharmaceutical Market Size Share by Type (2015-2020)
Table 35. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2021-2026)
Table 36. Global Antirheumatics Pharmaceutical Market Size Share by Application (2015-2020)
Table 37. Global Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 38. Global Antirheumatics Pharmaceutical Market Size Share by Application (2021-2026)
Table 39. North America Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 41. North America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 42. North America Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 43. North America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 44. North America Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 45. Europe Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 47. Europe Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 49. Europe Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 51. China Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 52. China Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 53. China Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 54. China Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 55. China Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 56. China Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 57. Japan Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 59. Japan Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 61. Japan Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 65. Southeast Asia Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 67. Southeast Asia Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 69. India Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 70. India Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 71. India Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 72. India Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 73. India Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 74. India Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Antirheumatics Pharmaceutical Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Antirheumatics Pharmaceutical Market Share (2019-2020)
Table 77. Central & South America Antirheumatics Pharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Antirheumatics Pharmaceutical Market Share by Type (2015-2020)
Table 79. Central & South America Antirheumatics Pharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Antirheumatics Pharmaceutical Market Share by Application (2015-2020)
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Product
Table 84. AbbVie Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 85. AbbVie Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Product
Table 89. Amgen Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 90. Amgen Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Roche Holding AG Company Details
Table 97. Roche Holding AG Business Overview
Table 98. Roche Holding AG Product
Table 99. Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 100. Roche Holding AG Recent Development
Table 101. Novartis International AG Company Details
Table 102. Novartis International AG Business Overview
Table 103. Novartis International AG Product
Table 104. Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 105. Novartis International AG Recent Development
Table 106. Johnson & Johnson Company Details
Table 107. Johnson & Johnson Business Overview
Table 108. Johnson & Johnson Product
Table 109. Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 110. Johnson & Johnson Recent Development
Table 111. Bristol-Myers Squibb Company Details
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Product
Table 114. Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 115. Bristol-Myers Squibb Recent Development
Table 116. Merck Business Overview
Table 117. Merck Product
Table 118. Merck Company Details
Table 119. Merck Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 120. Merck Recent Development
Table 121. UCB S.A. Company Details
Table 122. UCB S.A. Business Overview
Table 123. UCB S.A. Product
Table 124. UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 125. UCB S.A. Recent Development
Table 126. Eli Lilly and Company Company Details
Table 127. Eli Lilly and Company Business Overview
Table 128. Eli Lilly and Company Product
Table 129. Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2015-2020) (Million US$)
Table 130. Eli Lilly and Company Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Antirheumatics Pharmaceutical Market Share by Type: 2020 VS 2026
Figure 2. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 3. Steroidal Anti-Inflammatory Drugs Features
Figure 4. Slow Acting Drug Features
Figure 5. Immunological Preparation Features
Figure 6. Global Antirheumatics Pharmaceutical Market Share by Application: 2020 VS 2026
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Hospital and Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Antirheumatics Pharmaceutical Report Years Considered
Figure 11. Global Antirheumatics Pharmaceutical Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Antirheumatics Pharmaceutical Market Share by Regions: 2020 VS 2026
Figure 13. Global Antirheumatics Pharmaceutical Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Antirheumatics Pharmaceutical Market Share by Players in 2019
Figure 16. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Antirheumatics Pharmaceutical Revenue in 2019
Figure 18. North America Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AbbVie Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 27. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amgen Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 31. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Roche Holding AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 33. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis International AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 35. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Johnson & Johnson Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 37. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 39. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 41. UCB S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. UCB S.A. Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 43. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Eli Lilly and Company Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Figure 1. Global Antirheumatics Pharmaceutical Market Share by Type: 2020 VS 2026
Figure 2. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 3. Steroidal Anti-Inflammatory Drugs Features
Figure 4. Slow Acting Drug Features
Figure 5. Immunological Preparation Features
Figure 6. Global Antirheumatics Pharmaceutical Market Share by Application: 2020 VS 2026
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Hospital and Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Antirheumatics Pharmaceutical Report Years Considered
Figure 11. Global Antirheumatics Pharmaceutical Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Antirheumatics Pharmaceutical Market Share by Regions: 2020 VS 2026
Figure 13. Global Antirheumatics Pharmaceutical Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Antirheumatics Pharmaceutical Market Share by Players in 2019
Figure 16. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antirheumatics Pharmaceutical as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Antirheumatics Pharmaceutical Revenue in 2019
Figure 18. North America Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Antirheumatics Pharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AbbVie Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 27. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amgen Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 31. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Roche Holding AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 33. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis International AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 35. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Johnson & Johnson Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 37. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 39. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Merck Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 41. UCB S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. UCB S.A. Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 43. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Eli Lilly and Company Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed